ADAP Advocacy has released two infographics examining the relationship between the 340B Drug Pricing Program and the growing medical debt crisis affecting American patients. The publications, part of the organization's "340B Too Big to Fail" advocacy campaign, reveal significant disparities between the program's intended purpose and its actual impact on healthcare affordability.
The first infographic, "340B Too Big to Fail – Medical Debt – Part 1," demonstrates that despite the 340B program's expansion to $66 billion in annual activity, medical debt remains a devastating financial burden for countless Americans. Originally designed to help low-income patients access healthcare services, the program now primarily benefits hospitals that continue to charge patients unaffordable prices, resulting in overwhelming debt that disproportionately affects vulnerable populations.
The second infographic, "340B Too Big to Fail – Medical Debt – Part 2," documents how many 340B-participating hospitals employ aggressive, predatory debt collection practices against patients. These institutions frequently damage consumer credit reports through collection actions rather than providing the financial assistance and charity care required by law. The report indicates that hospitals are choosing to sue patients instead of offering reasonable pricing structures or robust financial aid programs.
Both infographics are available for download at https://www.adapadvocacy.org/publications.html#i as part of ADAP Advocacy's ongoing national campaign questioning whether the 340B program has become "too big to fail." The findings raise critical questions about healthcare system accountability and the need for reform to ensure that programs designed to help vulnerable patients actually deliver on their promises rather than contributing to their financial ruin.
The report's significance lies in its exposure of systemic failures within a major healthcare funding mechanism, highlighting how well-intentioned programs can be co-opted by institutional interests at the expense of patient welfare. This has implications for healthcare policy, hospital accountability, and the financial security of millions of Americans who face medical debt despite the existence of programs supposedly designed to protect them.
